Evaluating Non-invasive Biomarkers to Diagnose Asthma in Children Aged 6 to Under 18 with Inconclusive Spirometry in Primary Care
Led by Université de Sherbrooke · Updated on 2026-05-06
123
Participants Needed
3
Research Sites
30 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the use of accessible and non-invasive tests to improve asthma diagnosis in children aged 6 to under 18 years. Asthma is a common inflammatory disease affecting many children, but its diagnosis can be challenging due to limitations in current methods like spirometry and bronchial provocation testing, which is the gold standard but less accessible. This study aims to evaluate the usefulness of type 2 inflammation biomarkers, specifically fractional exhaled nitric oxide FeNO and blood eosinophil counts, to help diagnose asthma in children when spirometry results are inconclusive.
Participants referred for bronchial provocation testing after inconclusive spirometry will have their FeNO measured using a specialized device and undergo blood tests for eosinophil counts and other markers. Additional tests include allergy testing, inflammatory protein analysis, nasosorption, and urine analysis. These procedures will take place before the methacholine challenge test. The study is observational and will include 123 children to assess the diagnostic accuracy of these biomarkers compared to the standard bronchial provocation test.
During the study, participants will undergo medical assessments and complete standardized questionnaires about asthma control and quality of life. Researchers will analyze the diagnostic performance of FeNO and blood eosinophils and study their relationship with inflammatory proteins. Follow-up will include monitoring symptoms, medication use, and asthma exacerbations. The study also considers the impact of diagnostic delays on costs and environmental factors. Participation includes a baseline visit on the day of the methacholine challenge test, with no indication of long-term follow-up visits specified.
CONDITIONS
Brief Title
Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation
Research Team
S
Simon Couilard, MD MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Individuals aged 6 to under 18 years with symptoms suggesting asthma
Referred by primary care provider for methacholine bronchial provocation test
Spirometry results are inconclusive for asthma diagnosis
You will not qualify if you...
Use of inhaled or systemic corticosteroids within the previous 48 hours
Smoking within the previous 6 hours
Recent viral or bacterial respiratory infection within the past 4 weeks
Major cardiopulmonary diseases such as COPD, cystic fibrosis, bronchiectasis, or unstable heart disease
COPD defined by age 40 or older, permanent spirometry obstruction, and significant smoking history or alpha-1-antitrypsin deficiency
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for spirometry and assessment
Diagnostic Evaluation
Duration - 1 day
Participants undergo diagnostic tests including FeNO measurement, blood eosinophil count, nasosorption, and methacholine bronchial provocation testing to evaluate asthma.
1 baseline visit (in-person) including FeNO measurement, blood tests, nasosorption, and bronchial provocation test
Long-term Monitoring
Duration - Up to several months to years as per study follow-up
Participants are followed longitudinally to assess medication use, symptoms, quality of life, and asthma exacerbations.
Follow-up visits as scheduled to monitor asthma outcomes and collect data
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Evaluating the echOpen Ultrasound Probe for Faster Diagnosis at Jean Verdier Rapid Diagnostic Unit and Community Health Centers
Phase 4 Multicenter Study on Starting Airsupra in the Emergency Department to Improve Asthma Outcomes Compared to Usual Care
24-Week Real-World Study of Atectura Inhalation Capsule for Asthma Treatment in Patients Aged 12 to 100 Years
Phase II Study of Soluble Fiber Supplement to Improve Asthma in Children Ages 6 to 17
Study of Inflammatory Lung Diseases Including Asthma, COPD, Bronchiectasis, Cystic Fibrosis, PCD, and ILD to Understand Patient Characteristics and Improve Personalized Treatment
Phase 1 Randomized Study Comparing Pharmacokinetics of Two GSK5784283 Formulations in Healthy Adults by Injection
Evaluating Different Lung Function Tests Including Impulse Oscillometry to Diagnose Asthma in Adults at Portsmouth Hospital
Comparing Random Biopsies and Wide-Area Brush-Sampling for Barretts Esophagus Surveillance
A Multicenter Prospective Study on Detection of High-Grade Dysplasia and Esophageal Adenocarcinoma
Phase II Study of Two Doses of Inhaled Glycopyrronium with Budesonide and Formoterol Fumarate in Children Aged 4 to Under 12 Years with Asthma
A 4-Week Study to Test the Safety and Effectiveness of Fluticasone PropionateAlbuterol Sulfate Dry Powder Inhaler in People 12 Years and Older With Asthma
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Integrating blood eosinophils and exhaled nitric oxide (FeNO) in asthma diagnostic pathways for adults and children: the PROPULSION SANTÉ observational study with translational sub-studies (DIVE, DIVE2)-protocols.